Abstract:
End stage renal disease (ESRD) is a major health problem resulting
in conside rably increased morbidity and mortality, in decreased
qual ity of life and in high costs from renal replacement therapy
(RRT) . There are almost a million people that owe their lives to
dialys is and currently there is a 5 yea r survival rate of chronic renal
failure (CRF) patients . Today optimization of dialys is must
guarantee the full time restitution t o . society of a totally
rehab ilitated individual. This study a ims at investigating the
indications for commencing RRT and the optima l timing for
commencing the therapy , derived from comparative investigations ,
and incorporat ing factors affecting renal failure patients. It includes
the benefits of screening high risk individua ls for renal d isease, and
the benefits of managing factors affecting renal function to pro long
the pretreatment phase . It also looks at the effectiveness and
opt imal timing for commencing a pre-end stage renal disease
(PESRD) program, and considers whether there is patient
imp rovement in patients managed before development of renal
failure . Finally the study aims at investigating a way to reduce the
financial aspect related to treatment.
The research was twofold. First ly it involved a screening of 100
indiv iduals at tht: risk of chronic kidney disease (CKD), whereby a
serum creat in ine va lue was taken and the glomerular filtration rate
(OFR) calculated . Secondly it incorporated a biochemical and
clinical assessment of 95 CRF patients , a month prior to RRT, at
commencement of RRT, at I month and 3 months after RRT.
The screening revealed a mean creatin ine for males 128.45 flmollL
and for females 108 .99 flmollL. Twen ty-four percent (24%) of
patien ts had a OFR of between 30 - 59 , 6% of patients had a OFR of
between 15 29, and 3% of pat ients had a OFR of < 15
ml / minlI.73m2. T his strongly ind icates the need to screen
individua ls at risk for renal failure . The second part of the study
revealed that at commencement the mean OFR was 6.7
ml/ minlI .73m2, uremia , malnutrition, anemia, hyperparathyroid ism,
hyperphosphatemia, and other electro lyte imbalances were present ,
all predisposing a patient to a poor clinical outcome , an inc rease in
morbidity and mortal ity, and a dec rease in the qual ity of life. From
the investigation of patients commencing dialysis it was determined
that the optimal timing for commenc ing RRT was at the first clin ical
evidence of deterioration in the presence of uremia and / o r
malnutrit ion despite medical in tervention . It was found that RRT
should not be postponed until creatinine falls within mandated
range , as postponement adversely affects the patient, and the survival of dialysis patients depends on their condition at the time
dialysis is first initiated. Postponing treatment was found to have
adverse effects on patients commencing RRT, with an increase in
the number of acute hemodialysis (AHD) sessions and increase in
the number of access. Patients managed prior to commencement of
RRT and patients commencing dialys is at a higher GFR experienced
fewer complications, when compared to patients who commenced
dialysis later. There is an improvement in patient outcome in
patients managed prior to the commencement of RRT and it is
beneficial to manage factors affecting renal function in order to
prolong the pre-treatment phase . The PESRD educational program is
an effective component in the management of kidney disease and
initiating a PESRD program early in the course of kidney disease is
advantageous to the patient. The financial costs related to renal
replacement are extremely high, and can be reduced allowing more
patients to be treated for the same amount of money.
From the results obtained from the study it is clear that effective
PESRD management and early commencement of RRT in dialysis
patients leads to an improved qual ity of life, and a decline in
complications experienced.